Adenosine analogues as inhibitors of P2Y12 receptor mediated platelet aggregation
作者:James G. Douglass、J. Bryan deCamp、Emilee H. Fulcher、William Jones、Sanjoy Mahanty、Anna Morgan、Dima Smirnov、José L. Boyer、Paul S. Watson
DOI:10.1016/j.bmcl.2008.01.038
日期:2008.3
Modified adenosine derivatives may lead to the development of P2Y(12) antagonists that are potent, selective, and bind reversibly to the receptor. Analogues of 2',3'-trans-styryl acetal-N6-ureido-adenosine monophosphate were prepared by modification of the 5'-position. The resulting analogues were tested for P2Y(12) antagonism in a platelet aggregation assay.
修饰的腺苷衍生物可能导致有效,选择性和可逆地与受体结合的P2Y(12)拮抗剂的发展。通过修饰5′-位制备2′,3′-反式-苯乙烯基乙缩醛-N6-脲基-腺苷单磷酸酯的类似物。在血小板聚集试验中测试了所得类似物对P2Y(12)的拮抗作用。